The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Radiation Oncology

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Radiation Oncology


High impact information on Radiation Oncology


Chemical compound and disease context of Radiation Oncology


Biological context of Radiation Oncology


Associations of Radiation Oncology with chemical compounds


Gene context of Radiation Oncology


Analytical, diagnostic and therapeutic context of Radiation Oncology


  1. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07. Poulsen, M., Rischin, D., Walpole, E., Harvey, J., Mackintosh, J., Ainslie, J., Hamilton, C., Keller, J., Tripcony, L. J. Clin. Oncol. (2003) [Pubmed]
  2. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., Lamb, D., McClure, B. J. Clin. Oncol. (2005) [Pubmed]
  3. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Vu-Nishino, H., Tavassoli, F.A., Ahrens, W.A., Haffty, B.G. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  4. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. Poulsen, M., Rischin, D., Walpole, E., Harvey, J., Macintosh, J., Ainslie, J., Hamilton, C., Keller, J., Tripcony, L. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
  5. Ambiguities within the ASTRO consensus definition of biochemical failure: never assume all is equal. Williams, S.G. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  6. Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. Potters, L., Torre, T., Ashley, R., Leibel, S. J. Clin. Oncol. (2000) [Pubmed]
  7. Poly(ADP-ribose) polymerase in DNA damage-response pathway: implications for radiation oncology. Soldatenkov, V.A., Smulson, M. Int. J. Cancer (2000) [Pubmed]
  8. The American Radium Society. Radiation oncology in the 3rd millennium. Brady, L.W., Levitt, S.H. Radiology. (1998) [Pubmed]
  9. Professional and business characteristics of radiology groups in the United States: 1992. Sunshine, J.H., Bansal, S. Radiology. (1995) [Pubmed]
  10. Characterization of the behavior of three definitions of prostate-specific antigen-based biochemical failure in relation to detection and follow-up biases: comparison with the American Society for Therapeutic Radiology and Oncology consensus definition. Williams, S.G. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  11. The treatment of advanced juvenile nasopharyngeal angiofibroma. McGahan, R.A., Durrance, F.Y., Parke, R.B., Easley, J.D., Chou, J.L. Int. J. Radiat. Oncol. Biol. Phys. (1989) [Pubmed]
  12. Primary small intestinal lymphoma. Varghese, C., Jose, C.C., Subhashini, J., Roul, R.K. Oncology (1992) [Pubmed]
  13. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial--Trans-Tasman Radiation Oncology Group. O'Brien, P.C., Franklin, C.I., Poulsen, M.G., Joseph, D.J., Spry, N.S., Denham, J.W. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  14. The influence of dose on the long-term control of Classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy. Cooper, J.S. Int. J. Radiat. Oncol. Biol. Phys. (1988) [Pubmed]
  15. Episcleral iridium-192 wire therapy for choroidal melanomas. Valcárcel, F., Valverde, S., Cárdenes, H., Cajigal, C., de la Torre, A., Magallón, R., Regueiro, C., Encinas, J.L., Aragón, G. Int. J. Radiat. Oncol. Biol. Phys. (1994) [Pubmed]
  16. Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Wilson, L.D., Cooper, D.L., Goodrich, A.L., Friedman, N.D., Feldman, A.M., Braverman, I.M., Kacinski, B.M. Int. J. Radiat. Oncol. Biol. Phys. (1994) [Pubmed]
  17. Molecular biology in radiation oncology. Radiation oncology perspective of BRCA1 and BRCA2. Coleman, C.N. Acta oncologica (Stockholm, Sweden) (1999) [Pubmed]
  18. Does TANIS (T And N Integer Score) help predict survival? Hall, S.F., Groome, P.A., Dixon, P.F. The Journal of otolaryngology. (1997) [Pubmed]
  19. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Galvin, J.M., Ezzell, G., Eisbrauch, A., Yu, C., Butler, B., Xiao, Y., Rosen, I., Rosenman, J., Sharpe, M., Xing, L., Xia, P., Lomax, T., Low, D.A., Palta, J. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  20. Tissue levels of WR-1065, the active metabolite of amifostine (Ethyol), are equivalent following intravenous or subcutaneous administration in cynomolgus monkeys. Bachy, C.M., Fazenbaker, C.A., Kifle, G., McCarthy, M.P., Cassatt, D.R. Oncology (2004) [Pubmed]
  21. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study. Order, S.E., Siegel, J.A., Principato, R., Zeiger, L.E., Johnson, E., Lang, P., Lustig, R., Wallner, P.E. Int. J. Radiat. Oncol. Biol. Phys. (1996) [Pubmed]
  22. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation. Schreiber, A., Krause, M., Zips, D., Dörfler, A., Richter, K., Vettermann, S., Petersen, C., Beuthien-Baumann, B., Thümmler, D., Baumann, M. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. (2004) [Pubmed]
  23. The role of pentoxifylline as a modifier of radiation therapy. Nieder, C., Zimmermann, F.B., Adam, M., Molls, M. Cancer Treat. Rev. (2005) [Pubmed]
  24. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells. Bisht, K.S., Bradbury, C.M., Zoberi, I., Curry, H.A., Kaushal, A., Roti Roti, J.L., Gius, D. Int. J. Radiat. Biol. (2003) [Pubmed]
  25. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Kupelian, P.A., Potters, L., Khuntia, D., Ciezki, J.P., Reddy, C.A., Reuther, A.M., Carlson, T.P., Klein, E.A. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  26. Hyperthermia--the actual role in radiation oncology and future prospects. Part I. Molls, M. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. (1992) [Pubmed]
  27. Erythropoietin in radiation oncology - A review. 1st international conference, Freiburg, June 11-12, 1999. Henke, M., Guttenberger, R. Oncology (2000) [Pubmed]
  28. Prostate-specific antigen spikes after permanent prostate brachytherapy. Merrick, G.S., Butler, W.M., Wallner, K.E., Galbreath, R.W., Anderson, R.L. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  29. International Clinical Trials in Radiation Oncology. Large field trials. Rubin, P., Heilmann, H.P. Int. J. Radiat. Oncol. Biol. Phys. (1988) [Pubmed]
  30. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience. Lee, N., Hoffman, R., Phillips, T.L., Xia, P., Quivey, J.M., Weinberg, V., Hsu, I.C. Brachytherapy. (2002) [Pubmed]
  31. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone. Ragde, H., Grado, G.L., Nadir, B.S. Arch. Esp. Urol. (2001) [Pubmed]
  32. Factors contributing to delayed diagnosis in nasopharyngeal carcinoma. Leong, J.L., Fong, K.W., Low, W.K. The Journal of laryngology and otology. (1999) [Pubmed]
WikiGenes - Universities